“The pharmaceutical industry generates intense competition,†says Max Martin, COO for Mission Pharmacal.
(Oct 11, 2006)
Supply Chain
Is Excess Regulation to Blame for Soaring Pharmaceutical Prices?
Development times, about 4-1/2 years long, were stable for the two decades prior to the 1962 Kefauver-Harris Amendments. Since then, development times have soared.
(Nov 9, 2004)Pharmaceutical industry group concludes first phase of EPC/RFID tests
Findings, based on shipping, tracking and tracing nearly 13,500 packages of pharmaceuticals over an eight week period, show that EPC/RFID can help satisfy regulatory and retailer requirements, increas
(Oct 12, 2004)Reliant Pharmaceuticals deploys Ariba Spend Management
Reliant selected the Ariba Spend Management applications: Ariba Analysis, Ariba Buyer, Ariba Contracts, Ariba Invoice and Ariba Travel & Expense to reduce the costs, resources, and time associated wit
(Dec 20, 2002)Yamanouchi Deploys Ariba Spend Management
According to Ariba, Yamanouchi, the first Japanese-based pharmaceutical company to implement Ariba Buyer, is using the solution to centralize and streamline its
(Dec 3, 2002)Quick Take: Yankee Group finds, even in tight economy, partner integration remains a priority
(Aug 27, 2002)
Outsourcing your clinical supply activities
(Aug 13, 2002)
